Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
Physician/CEO/Entrepreneur
Dr. David Genecov is a dedicated physician in the field of cleft lip and palate, craniofacial and pediatric plastic surgery. David has over 25 years of experience as a practicing surgeon, private investor, chief executive and director in both public and private companies. Dr. Genecov was Co-Founder and former director of AveXis, Inc. (NASDAQ: AVXS), acquired by Novartis in 2018 for $8.7 billion, which develops proprietary gene therapies for rare neurological genetic diseases. David also founded or co-founded numerous companies in the health care industry, including Skin Within, Inc., Synergy Surgical Services LLC, Biolife Cell Bank LLC and is the owner and director of The Modern Medical Spa. He was a director and investor of CerSci Therapeutics, a pharmaceutical company using non opioid approaches to treat pain, which was sold to Acadia Pharmaceuticals (NASDAQ: ACAD) in 2020. David is a director and co-founder of Cessation Therapeutics, Inc., a company based on the treatment of substance use disorders with an immunotherapy approach using monoclonal antibodies and vaccines. Currently, Dr. Genecov is a cofounder and serves as the President and CEO of Dialectic Therapeutics, Inc., a Dallas-based precision oncology company. DT uses innovative protein degradation technologies to treat cancer; currently in clinical trials with their lead candidate DT2216
A 4th generation Texan, Dr. Genecov graduated from the Plan II Honors Program at the University of Texas at Austin (1985). David began his medical education at the University of Texas-Health San Antonio (1990) and then completed residencies in General Surgery at West Virginia University (1995) and in Plastic Surgery at Wake Forest University (1997).
Dr. Genecov completed fellowship training in Craniofacial Surgery at the International Craniofacial Institute where he is now the director emeritus.. He is published in over 50 peer reviewed journals, books and videos. His research interests are in bone regeneration, stem cell therapies and new treatments for complex craniofacial anomalies. He is an adjunct associate professor at Baylor College of Dentistry at the Texas A&M Health Science Center and teaches residents and graduate students about cleft lip and palate and craniofacial surgery.
Dr. Genecov maintains American Board of Medical Specialties board certificates in plastic and reconstructive surgery. David has served as a trustee at St. Mark’s School of Texas, where he was also chairman of the Education Committee and on the Executive Committee. Additionally, he has served as a director for the Dallas Jewish Federation, Congregation Shearith Israel, and The DISD PTECH advisory Board. Dr. Genecov currently serves on the Plan II Visiting Committee, College of Liberal Arts Advisory Board, The Development Board and the Chancellor’s Executive Committee, all at The University of Texas at Austin. He is also a director at the Dallas Opera where he is Co-chair of the Digital Strategy Advisory Council. In 2021, Dr. Genecov will join the Executive Advisory Council at the George Bush Presidential Center.
David has been recognized for his medical and philanthropic service by the Dallas Chapter of Hadassah, The Bnai Zion Foundation, D Magazine, Texas Monthly, Consumer Choice Awards, DFW Alliance for Healthcare Excellence, The Dallas Jewish Historical Society, The Torah Day School, Bryan’s House and the Be the Difference Foundation.